← Browse by Condition
Medical Condition
high grade gliomas
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06607692 Phase 2
Recruiting
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
Enrollment
25 pts
Location
Spain
Sponsor
Fundación de investigación HM
NCT06740097
Recruiting
Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery
Enrollment
50 pts
Location
Finland, Norway
Sponsor
Kuopio University Hospital
NCT06975332
Recruiting
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
Enrollment
35 pts
Location
Poland
Sponsor
Medical University of Warsaw
NCT06018363 Phase 1, Phase 2
Recruiting
Clinical Study on the Treatment of Malignant Brain Glioma by QH104 Cell Injection
Enrollment
25 pts
Location
China
Sponsor
Dushu Lake Hospital Affiliated...